- MENU
- HOME
- SEARCH
- WORLD
- MAIN
- AFRICA
- ASIA
- BALKANS
- EUROPE
- LATIN AMERICA
- MIDDLE EAST
- United Kingdom
- United States
- Argentina
- Australia
- Austria
- Benelux
- Brazil
- Canada
- China
- France
- Germany
- Greece
- Hungary
- India
- Indonesia
- Ireland
- Israel
- Italy
- Japan
- Korea
- Mexico
- New Zealand
- Pakistan
- Philippines
- Poland
- Russia
- South Africa
- Spain
- Taiwan
- Turkey
- USA
- BUSINESS
- WEALTH
- STOCKS
- TECH
- HEALTH
- LIFESTYLE
- ENTERTAINMENT
- SPORTS
- RSS
- iHaveNet.com: Health
Harvard Health
Harvard Health Letters
Bayer first started selling aspirin as a pain and fever reliever over 100 years ago. Now we've got a slew of other choices, including over-the-counter drugs like acetaminophen (Tylenol), ibuprofen (Advil, Motrin, other brands), and naproxen (Aleve), so aspirin for pain relief seems out of date. Children don't grow up taking aspirin like they used to, because it's been linked to Reye's syndrome, a rare but potentially fatal childhood condition that involves swelling of the liver and brain. And there's no doubt aspirin can be hard on the stomach; it can lead to ulcers if taken often.
Even so, its value as a pain reliever is underestimated these days, and in many cases aspirin could be used instead of medications that are more expensive, more heavily marketed, and often both. For example, there was a report in
A SECOND CAREER
Plenty of people are still taking aspirin -- 50 million Americans by one count -- because it has enjoyed a remarkable second career in cardiovascular prevention. There's wide agreement that if you have had a heart attack or stroke, taking low doses of aspirin on a regular basis (daily or every other day) will reduce the likelihood of having another one.
Research has also shown that a low-dose aspirin habit reduces the risk of a first-time heart attack or stroke, although the way the risk-benefit math works out, only people who have a number of risk factors for cardiovascular disease are advised to take aspirin.
Now researchers are trying to figure out if aspirin might also have a protective effect against cancer. Some of the most promising results have been for colon cancer and the polyps that typically precede it.
The problem is that randomized trials, which usually carry more weight than epidemiologic findings, haven't been so encouraging. The Women's Health Study, sponsored by the
Results from the study, reported in 2005, didn't show aspirin as having any effect on any cancer. The
One explanation for the mixed results is that the dose of aspirin used in the randomized studies, while adequate for cardiac prevention, might be too small for colon cancer purposes. Data from the epidemiologic studies and other research suggests that higher doses of aspirin (perhaps 325 mg a day, or even more) may be needed before colon cancer prevention kicks in. But doses that high also increase the risk of serious side effects, like hemorrhagic stroke, so the benefits have to be weighed carefully against the risks.
Some experts are reserving judgment. In 2009, a group who met at the
Aspirin inhibits the cyclooxygenase (COX) enzymes, which come in two forms, COX-1 and COX-2. The COX enzymes play a crucial role in several "pathways," the cascades of biochemical events that determine how our bodies function. By inhibiting COX-1, aspirin winds up making platelets less "sticky," so blood is less likely to clot, which makes a heart attack or stroke less likely. COX-1 also produces hormone-like molecules called prostaglandins that protect the stomach, so, by interfering with COX-1, aspirin also makes the stomach lining more vulnerable to ulcers.
COX-2 stirs up fever and inflammation; by inhibiting COX-2, aspirin helps put out those fires. Inhibition of COX-2 may also explain aspirin's anti-cancer effects, although cancer exploits multiple pathways, which is one of the many reasons it's so difficult to prevent and treat.
[See 14 Things You Might Not Know About Aspirin
A NEW TWIST
In
Their study included about 4,000 women in the Nurses' Health Study who'd been diagnosed with breast cancer over a 26-year period and who had supplied researchers with information about their use of aspirin. The
So where does this leave us? With aspirin as a fine but unfashionable reliever of pain and fever, a strong defender against heart disease and stroke, but a bit iffy as a preventer of cancer. - Harvard Health Letter
Available at Amazon.com:
Copyright © Harvard Health. All rights reserved.
AGING | ALTERNATIVE | AILMENTS | DRUGS | FITNESS | GENETICS | CHILDREN'S | MEN'S | WOMEN'S
Health - Can Aspirin Do That, Too?